Improving therapy outcomes with a Meep companion
Improve the clinical outcomes of a novel therapeutic through a bespoke home monitoring companion. We can bring a complex lab test to our platform and in the hands of patients, providing a patient-centric therapy experience.
Better outcomes
Home monitoring of key biomarkers can lead to a more timely therapeutic intervention dampening disease progression and avoiding complications.
Improved patient experience
With a therapy-branded home companion patients avoid long and frequent travel to the hospital for therapy followup. The anxiety of going in remission is reduced while a more frequent and personal follow-up can be provided.
Reduced toxicity
By tracking toxicity related biomarkers the therapy can be dosed more precisely to the patient's needs, reducing side effects.
Higher adherence
Therapy adherence and patient engagement can be increased through the use of digital companions. The Meep minilab comes with a smartphone app enhancing the personal experience.
A therapy-branded biomarker monitoring device
Meep engages in custom development of a set of disease-specific biomarkers. If a lab test exists, it is typically portable to the Meep minilab. As such, the patient can enter a new treatment regime where a novel therapeutic is combined with a specific monitoring device, leading to optimal performance of the therapeutic.
Let us know which therapy you want to augment with personal monitoring.
Discover our collaboration modalities.
A succesful track record in bringing lab tests to the patient
We have developed a home monitoring test for a leading biopharmaceutical company in the hematology space. We could show that our handheld device outperformed the clinical standard used for quantifying enzymatic activity, at 500x lower device cost:
- Better LOD & dynamic range
- Equivalent accuracy & precision
- No interference
Therapeutic areas of focus
/> Immunology
Many immunological conditions come with debilitating flares. These are targeted by different therapeutic modalities that often come with severe immunosupressent side effects. By anticipating these flares and intervening timely we can enhance the therapeutic outcome of the therapy.
/> Hematology
Hematological disorders often revolve around deficiencies in the complex coagulation cascade. Although new therapies have varying approaches to enact on this cascade, enzymatic monitoring for both efficacy & toxicity is usually key. This is where Meep can help.
Fuel your R&D pipeline
Our home companion does not only bring added value in clinical practice, but it can also generate valuable insights during the R&D phase of a therapy.
Gain insights
All the data that is being generated at home by a specific patient is accessible through our cloud system, giving invaluable physiological insights regarding a specific patient population. This can accelerate the development of new therapeutic solutions.
Accelerate clinical trials
Clinical trials could be greatly accelerated if patients could follow-up on their therapy candidates from home. More data could be generated, lower drop-out rates would be observed and clinical trials would be less costly overall.
